Suppr超能文献

[口服抗凝治疗的控制:107例患者中Quick法与比色法测定X因子的比较]

[Control of oral anticoagulation: comparison between Quick and colorimetric factor X determination in 107 patients].

作者信息

Lämmle B, Eichlisberger R, Hänni L, Bounameaux H, Marbet G A, Duckert F

出版信息

Schweiz Med Wochenschr. 1979 Aug 7;109(30):1115-9.

PMID:472699
Abstract

Since monitoring of oral anticoagulation (OA) by prothrombin time (PT) is a source of standardization difficulties, the authors have tested another approach. 107 patients under long term OA were monitored by both PT and a colorimetric factor X assay (in vitro activation of factor X with RVV and assessment of amidolytic activity towards S-2222). The PT values were between 10 and 34% (therapeutic range 15--25%), and factor X levels were between 10 and 44% (therapeutic range 16--24%). The correlation between the two methods was highly significant (r = 0.65, p less than 0.001). In 68% of the patients the two tests gave the same information (55 subjects were adequately, 16 insufficiently and 2 over-anticoagulated). For a slightly broader therapeutic range (PT 15--30%, corresponding to 16--28% factor X) concordant information was obtained in 82% of the patients. During stable OA, PT and factor X assay gave very similar information. An advantage of the latter method is the possibility of automation, while a disadvantage is its insensitivity to factor VII.

摘要

由于通过凝血酶原时间(PT)监测口服抗凝治疗(OA)存在标准化困难,作者测试了另一种方法。对107例长期接受OA治疗的患者同时进行了PT和比色法X因子检测(用蛇毒凝血活酶体外激活X因子并评估对S-2222的酰胺水解活性)。PT值在10%至34%之间(治疗范围为15%至25%),X因子水平在10%至44%之间(治疗范围为16%至24%)。两种方法之间的相关性非常显著(r = 0.65,p < 0.001)。在68%的患者中,两项检测给出了相同的信息(55例抗凝充分,16例不足,2例抗凝过度)。对于稍宽的治疗范围(PT为15%至30%,对应X因子为16%至28%),82%的患者获得了一致的信息。在稳定的OA治疗期间,PT和X因子检测给出了非常相似的信息。后一种方法的一个优点是可以实现自动化,而缺点是对VII因子不敏感。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验